Joseph A. Franciosa

Joseph A. Franciosa's AcademicInfluence.com Rankings

Joseph A. Franciosa

Philosophy

#8166

World Rank

#11494

Historical Rank

Logic

#5196

World Rank

#6575

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Joseph A. Franciosa's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Joseph A. Franciosa Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Joseph A. Franciosa's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. (1986) (1910)
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study (1987) (1108)
Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. (1981) (898)
Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. (1983) (692)
Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. (1988) (567)
Vasodilator Therapy of Cardiac Failure (1977) (412)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
Treatment of refractory heart failure with infusion of nitroprusside. (1974) (343)
IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION (1972) (333)
Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. (1984) (293)
Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. (1979) (288)
Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure (1980) (271)
Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. (1982) (237)
Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. (1977) (218)
Vasodilator therapy of cardiac failure (second of two parts). (1977) (210)
Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. (1984) (196)
Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. (1980) (174)
Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. (1982) (172)
Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. (1972) (162)
Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. (1985) (161)
Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. (1980) (153)
Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. (1984) (137)
Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. (1978) (135)
Nitrate Therapy for Congestive Heart Failure (1978) (133)
Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. (1985) (132)
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. (1987) (123)
Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. (1978) (110)
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. (1974) (101)
Immediate Effects of Hydralazine-Isosorbide Dinitrate Combination on Exercise Capacity and Exercise Hemodynamics in Patients with Left Ventricular Failure (1979) (100)
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. (2002) (98)
Comparative Hemodynamic Effects of Chewable Isosorbide Dinitrate and Nitroglycerin in Patients with Congestive Heart Failure (1975) (90)
Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. (1979) (85)
Exercise testing in chronic congestive heart failure. (1984) (83)
Hemodynamic effects of vasodilators and long-term response in heart failure. (1984) (72)
Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure. (1978) (71)
Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. (1986) (71)
Hyponatraemia as a marker for high renin heart failure. (1982) (70)
Ventricular dimensions measured noninvasively by echocardiography in the awake dog. (1976) (68)
Antihypertensive and Hemodynamic Properties of the New Beta Adrenergic Blocking Agent Timolol (1973) (66)
Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure. (1980) (65)
Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36. (2009) (64)
TREATMENT OF REFRACTORY HEART FAILURE WITH INFUSION OF NITROPRUSSIDE (1975) (59)
Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure. (1982) (56)
Selection of vasodilator, inotropic or combined therapy for the management of heart failure. (1978) (56)
Nitrate therapy for congestive heart failure. (1978) (54)
Evaluation of the CO2 Rebreathing Cardiac Output Method In Seriously III Patients (1977) (49)
Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure. (1985) (48)
Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol. (1980) (46)
Treatment of heart failure in African Americans: a consensus statement. (2010) (46)
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. (2007) (45)
β-Blocker dosing in community-based treatment of heart failure (2007) (44)
Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarction. (1986) (44)
Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. (2004) (43)
Effect of propafenone on left ventricular ejection fraction. (1984) (42)
Effect of Hydralazine on Renal Failure in Patients with Congestive Heart Failure (1980) (40)
Acquired coronary artery fistula to the left ventricle after acute myocardial infarction. (1986) (39)
Vasodilator therapy of cardiac failure: (first of two parts). (1977) (38)
Validation of the CO2 rebreathing method for measuring cardiac output in patients with hypertension or heart failure. (1976) (36)
Epidemiologic patterns, clinical evaluation, and long-term prognosis in chronic congestive heart failure. (1986) (36)
Progressive myocardial dysfunction associated with increased vascular resistance. (1980) (32)
Heart Rate Responses During Singles and Doubles Tennis Competition (1987) (31)
Why patients with heart failure die: hemodynamic and functional determinants of survival. (1987) (30)
Normal cardiac output during beta blockade with timolol in hypertensive patients (1975) (28)
Percutaneous transluminal coronary angioplasty of one vessel for refractory unstable angina pectoris: efficacy in single and multivessel disease. (1988) (28)
Coronary artery occlusion due to neoplasm. A rare cause of acute myocardial infarction. (1971) (28)
Short‐Term Systemic Hemodynamic Adaptation to Beta‐Adrenergic Inhibition with Atenolol in Hypertensive Patients (1981) (27)
The potential role of community-based registries to complement the limited applicability of clinical trial results to the community setting: heart failure as an example. (2004) (27)
Predictive value of M-mode echocardiography in patients with congestive heart failure. (1986) (27)
Beta-adrenergic blocking agents: past, present, and future perspectives. (1999) (27)
Intravenous amrinone: an advance or a wrong step? (1985) (26)
Hemodynamic effects of nitroprusside and furosemide in left ventricular failure (1982) (26)
The African-American Heart Failure Trial: background, rationale and significance. (2002) (26)
Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias. (1985) (25)
Left ventricular thrombi diagnosed by echocardiography in patients with acute myocardial infarction treated with intracoronary streptokinase followed by intravenous heparin. (1985) (25)
Contrasting acute and chronic effects of nitrates on exercise capacity in heart failure (1979) (22)
High renin in heart failure: a manifestation of hyponatremia. (1979) (22)
Arterial pressure as a determinant of left ventricular filling pressure after acute myocardial infarction. (1974) (22)
Beta-blocker dosing in community-based treatment of heart failure. (2007) (21)
Left and right ventricular dimensions during ventricular fibrillation in the dog. (1978) (20)
Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure. (1983) (20)
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE) * ** (2000) (19)
Hemodynamic improvement with hydralazine in left heart failure (1976) (19)
Adverse effects of long-term amrinone administration in congestive heart failure. (1983) (16)
"Optimal" left ventricular filling pressure during nitroprusside infusion for congestive heart failure. (1983) (16)
Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure. (1979) (15)
Comparative haemodynamic and metabolic effects of vasodilator and inotropic agents in experimental myocardial infarction. (1978) (14)
Equivalent hemodynamic effects on nitroprusside and hydralazine nitrate combination in left ventricular failure (1976) (14)
Effects of a New Angiotensin Converting Enzyme Inhibitor, Enalapril, in Acute and Chronic Left Ventricular Failure in Dogs (1983) (14)
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial). (2007) (12)
Right ventricular unloading: lessons from the left. (1981) (12)
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry. (2003) (11)
Comparative hemodynamic effects of nitroglycerin forms in heart failure (1975) (10)
Application of noninvasive techniques for measuring cardiac output in hypertensive patients. (1988) (10)
Acute hemodynamic effects of norepinephrine inhibition in patients with severe chronic congestive heart failure. (1989) (10)
Significance of hypotension preceding fatal ventricular tachyarrhythmias in post-coronary obstruction sudden death. (1981) (10)
Predictors of clinical outcomes in patients given carvedilol for heart failure. (2006) (9)
Nitric oxide's role in heart failure: pathophysiology and treatment. Introduction. (2003) (9)
Hemodynamic and metabolic response to nitroprusside infusion in experimental acute myocardial infarction (1973) (9)
Effect of inhibition of platelet function with carbenicillin or aspirin on experimental canine sudden death. (1981) (8)
Cardiovascular disease in the elderly. Heart failure. (1987) (8)
Heart failure in community practice: relationship to age and sex in a beta-blocker registry. (2006) (8)
Isosorbide dinitrate and exercise performance in patients with congestive heart failure. (1985) (8)
Ephedrine-nitroprusside combination in congestive heart failure (1978) (8)
β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry (2005) (7)
Systemic and regional hemodynamics after coronary embolization in closed chest dogs (1974) (7)
Efficacy of Long-Term Nitrate Treatment in Chronic Left Ventricular Failure (1981) (6)
Congestive cardiomyopathy: pathophysiology and response to therapy. (1978) (6)
Fixed combination isosorbide dinitrate–hydralazine for nitric-oxide-enhancing therapy in heart failure (2006) (5)
Nitroprusside infusion in acute myocardial infarction. (2009) (5)
Long-term vasodilator therapy of chronic left ventricular failure: does it work? (1984) (5)
Site of premature ventricular contractions demonstrated by echocardiography. (1981) (5)
Cardiovascular clinical pharmacology of impedance reducing agents. (1981) (5)
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians. (2000) (5)
Nitroprusside and dobutamine effect on myocardial oxygen supply/demand in experimental myocardial infarction (1974) (5)
Hemodynamic effects of converting enzyme inhibitor in congestive heart failure (1978) (5)
Commentary on the use of run-in periods in clinical trials. (1999) (4)
Importance of state of consciousness in determining hemodynamic responses to acute coronary occlusion in the dog. (1977) (4)
Role of ventricular function in determining exercise capacity in patients with chronic left ventricular failure. (1986) (4)
Effect of the left ventricle on the right ventricle. (1987) (4)
Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure. (1983) (3)
Beta-receptor-active agents: role of partial agonists in patients with heart failure. (1989) (3)
Clinical application of sodium nitroprusside. (1977) (3)
Slow-channel calcium blockers in heart failure: a plea for cautious optimism. (1981) (3)
Hypertensive complications--a common geriatric problem. (1980) (3)
Nitrates as Adjuvant Therapy for Chronic Congestive Heart Failure (1986) (2)
The role of vasodilators in managing congestive heart failure. (1980) (2)
Course of arterial and pulmonary wedge pressures after acute myocardial infarction: Effect of nitroprusside (1978) (2)
Treatment of heart failure in African Americans: executive summary. (2010) (2)
Current problems in hypertension (1984) (2)
Outflow Resistance as a Regulator of Left Ventricular Performance (1978) (2)
Lack of acute effects of nitrates on exercise capacity in congestive heart failure (1978) (2)
Background and overview of a symposium to update the biology of atherosclerosis and its implications for treatment strategies. (2003) (2)
821-2 Characteristics of heart failure patients in clinical practice: How do they relate to ejection fraction? (2004) (2)
Pericardial effusion with pulmonary and cutaneous manifestations. (1986) (2)
Effect of Systemic Vasoconstriction on Left Ventricular Function: Implications Regarding Hypertension and Heart Failure (1981) (1)
Limitations of the use of clinical trial results in managing heart failure in the African-American community: a time for active participation in generating applicable data. (2003) (1)
Should Hemodynamic Guidance for Treatment of Acute Decompensated Heart Failure be Driven by the Right? (2018) (1)
Preload reduction vs vasodilators in heart failure (1976) (1)
Hyponatraemia asamarker forhighrenin heart failure (1982) (1)
Titration, tolerability, and results of beta-blocker therapy for heart failure in the community: Findings of a community-based registry (2003) (1)
Lack of Tolerance Development to the Hemodynamic Effects of Nitrates in Patients with Chronic Congestive Heart Failure (1983) (1)
Left and right ventricular pressure diameter relationships during ventricular standstill in the dog. (1982) (1)
Current clinical status of nitroglycerin and other nitrates. (1978) (1)
821-3 Evaluation of beta-blocker does in community-based treatment of heart failure (2004) (1)
1172-71 Practical predictors of clinical outcomes in patients initiating beta-blockers for heart failure: Findings of a community-based registry (2004) (1)
Vasodilator Therapy of Heart Failure: influence of prerandomization variables (2005) (0)
Impairment by Propranolol but not Oxprenolol (2017) (0)
Ari Cedars Giovanni Filardo (2017) (0)
CARDIAC FAILURE EDITOR-IN-CHIEF (2009) (0)
Subject Index, Vol. 75, 1988 (1988) (0)
Protocol Development and Preparation for a Clinical Trial (2012) (0)
Nitroglycerin and nitrates in congestive heart failure. (1980) (0)
Beta-blockers in patients with left ventricular ejection fraction >40%: results from a community-based registry (2003) (0)
Inpharzam medical forum--'heart failure today'. (1988) (0)
GEORGE A . BROWN MEMORIAL LECTURE Carotid and Aortic Regulation of Arterial Blood Pressure (2005) (0)
Acute onset of dyspnea following coronary artery bypass surgery. (1986) (0)
An Arkansas experience with percutaneous transluminal coronary angioplasty. (1985) (0)
The Effect of Carbenicillin and Aspirin in the Prevention of Experimental Sudden Death in the Dog (1979) (0)
The role of new antihypertensive drugs. (1988) (0)
A Shared Destiny—Community Effects of Uninsurance (2004) (0)
Comparative HemodynamicEffects ofChewable Isosorbide Dinitrate andNitroglycerin inPatients withCongestive HeartFailure (1975) (0)
Cardiovascular disease: A three-article symposium (1982) (0)
WOMEN HAVE GREATER MID-TERM QUALITY OF LIFE BENEFIT THAN MEN AFTER VALVULAR SURGERY (2011) (0)
Recent advances in the treatment of malignant ventricular arrhythmias: new hope for prolonged survival. (1985) (0)
Hypertensive left heart failure: pathogenesis and therapy. (1981) (0)
Short-term systemic hemodynamic adaptation to antihypertensive therapy with atenolol (1979) (0)
Minoxidil inpatients withchronic left heartfailure: contrasting hemodynamic andclinical effects ina controlled trial (1984) (0)
Improved renal function with hydralazine in patients with congestive heart failure (1979) (0)
CONGESTIVE HEART FAILURE Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure (2005) (0)
Nitroprusside in acute congestive heart failure. (1977) (0)
Converting Enzyme Inhibitors in the Treatment of Heart Failure (1981) (0)
Vasodilators for heart failure--useful or useless? (1988) (0)
A Vasodilator Is a Vasodilator Is a Vasodilator? (2015) (0)
CHRONIC VASODILATOR THERAPY IN THE MANAGEMENT OF CARDIOGENIC SHOCK AND INTRACTABLE LEFT VENTRICULAR FAILURE (1975) (0)
Current indications for vasodilator therapy for left ventricular failure. (1985) (0)
Beta-blockade in women with heart failure in the community setting: insights from a large prospective beta-blocker registry (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Joseph A. Franciosa?

Joseph A. Franciosa is affiliated with the following schools:

University of Pennsylvania